ClinicalTrials.Veeva

Menu

The Effect of a Natural Extract on Glucose Fluxes After Consumption of a Wheat Product

Unilever logo

Unilever

Status

Completed

Conditions

Healthy

Treatments

Other: Glucose solution
Dietary Supplement: Natural fruit extract
Other: Placebo

Study type

Interventional

Funder types

Industry

Identifiers

NCT02662738
FDS-NAA-1650

Details and patient eligibility

About

This study is to quantify the effect of a natural fruit extract added to a wheat product on the time needed to absorb 50% of the apparent total of available exogenous carbohydrate (RaE * Time). In addition the different glucose fluxes will be quantified (RaE, EGP and GCR)

Enrollment

12 patients

Sex

Male

Ages

20 to 50 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Healthy Caucasian male.
  • Body mass index (BMI) ≥ 18.0 and ≤ 25.0 kg/m2.
  • Apparently healthy: no medical conditions which might affect the study measurements including diabetes type 1 and type 2, gastrointestinal dysfunction, gastrointestinal surgery and inflammatory diseases.
  • Fasting blood glucose value of volunteer is ≥ 3.4 and ≤ 6.1 mmol/liter (i.e. 62- 110 mg/dl) at screening.
  • HbA1c ≤ 6.5 % (48 mmol/mol).

Exclusion criteria

  • Use of antibiotics within 3 months before Day 1; use of any other medication except paracetamol within 14 days before Day 1.

Trial design

Primary purpose

Basic Science

Allocation

Randomized

Interventional model

Crossover Assignment

Masking

Single Blind

12 participants in 3 patient groups, including a placebo group

A wheat product
Active Comparator group
Description:
A wheat product (containing 2% 13C-universally-labeled wheat) with natural fruit extract added.
Treatment:
Dietary Supplement: Natural fruit extract
Control
Placebo Comparator group
Description:
A wheat product (containing 2% 13C-universally-labeled wheat) without natural fruit extract added.
Treatment:
Other: Placebo
Glucose solution
Other group
Description:
A solution of 50g glucose of which 2% 13C-universally-labeled glucose (2%) and unlabeled glucose (98%) in 250 mL water.
Treatment:
Other: Glucose solution

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems